Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets

v3.21.2
Condensed Balance Sheets - USD ($)
Sep. 30, 2021
Dec. 31, 2020
Current Assets    
Cash $ 228,930 $ 1,044,177
Prepaid Expenses 826,000 751,781
Total Current Assets 1,054,930 1,795,958
Investments held in Trust Account 402,518,127 402,500,000
Total Assets 403,573,057 404,295,958
Current liabilities    
Accounts payable 185,829 767,969
Accrued expenses 446,199 428,433
Note payable – related party 1,250,000 0
Due to related party 104,000 14,000
Total current liabilities 1,986,028 1,210,402
Deferred underwriting commissions 14,087,500 14,087,500
Derivative warrant liabilities 25,950,500 29,370,333
Other derivative instruments 5,048,594 0
Total Liabilities 47,072,622 44,668,235
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 36,208,820 and 35,462,772 shares subject to possible redemption at $10.00 per share at September 30, 2021 and December 31, 2020, respectively 402,500,000 402,500,000
Shareholders' Deficit    
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding
Additional Paid in Capital 0 0
Retained Earnings (Deficit) (46,000,571) (42,873,283)
Total Shareholders' Deficit (45,999,565) (42,872,277)
Total Liabilities and Shareholders' Deficit 403,573,057 404,295,958
Common Class B [Member]    
Shareholders' Deficit    
Common stock $ 1,006 $ 1,006